Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients With Advanced Lung Adenocarcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is a Multiple centers, open design aimed at evaluating the safety,efficacy and Production feasibility of Autologous Tumor-Infiltrating Lymphocyte (GTE-001 injection ) for treatment of patients with Advanced lung adenocarcinoma,And evaluate potential biomarkers related to GTE-001 activity.
Epistemonikos ID: 8fb457ca14c4051b91ffcdd076cd6b752ecce958
First added on: Aug 01, 2024